Smart scans guide tailored therapy for hodgkin lymphoma patients

NCT ID NCT03233347

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a personalized approach for people with early-stage Hodgkin lymphoma. Doctors use PET scans to decide if standard chemotherapy alone is enough or if adding immunotherapy drugs can improve results. The goal is to boost survival while limiting unnecessary treatment. About 82 participants will receive a combination of chemotherapy and immune-boosting drugs based on their scan results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANN ARBOR STAGE IB HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

classic Hodgkin lymphoma Hodgkins lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carolinas Medical Center/Levine Cancer Institute

    Charlotte, North Carolina, 28203, United States

  • City of Hope Comprehensive Cancer Center

    Duarte, California, 91010, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, 07601, United States

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, 68198, United States

  • University of Pennsylvania/Abramson Cancer Center

    Philadelphia, Pennsylvania, 19104, United States

  • University of Washington Medical Center - Montlake

    Seattle, Washington, 98195, United States

  • Vanderbilt University/Ingram Cancer Center

    Nashville, Tennessee, 37232, United States